MISITATUG BLIVEDOTIN
UNII NS5GTS5FLQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Misitatug Blivedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NS5GTS5FLQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2767203-06-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NS5GTS5FLQ
CAS Registry Number
2767203-06-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MISITATUG BLIVEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174395
National Cancer Institute reference terminology for clinical and research data.
INN ID
12877
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Misitatug Blivedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MISITATUG BLIVEDOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN-MUS MUSCULUS MONOCLONAL RC88 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RC88 .KAPPA.-CHAIN, DIMER, REDUCED, CYCLIC BIS(THIOETHER) WITH N-METHYL-N-(((4-((N-(2-((3-OXO-3-(TETRAHYDRO-3,5-BIS(3-MERCAPTO-1-OXOPROPYL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)THIO)ACETYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS MSLN (MESOTHELIN, PRE-PRO-MEGAKARYOCYTE-POTENTIATING FACTOR, MEGAKARYOCYTE-POTENTIATING FACTOR, MPF, CAK1)); CONJUGATED ON AN AVERAGE OF 4 CYSTEINYL RESIDUES TO MONOMETHYLAURISTATIN E (MMAE), WITH A RATIO OF 1 TO 2, VIA A CLEAVABLE DIVALENT LINKER
MISITATUG BLIVEDOTIN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus